SON Options Flip as Earnings Land
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Sonoco Products Company reported Q3 results on October 21 with short sellers holding a meaningful position and options markets making a dramatic pivot overnight.
The options market told two completely different stories on consecutive days. On October 19, the put/call ratio was 0.145, one of the most call-heavy readings of the past year. By October 20, the day after the print, it had swung to 1.58, a new 52-week high and 4.3 standard deviations above the 20-day mean of 0.36. That is a near-complete reversal in options sentiment within 24 hours, with traders who had been positioned for upside now loading put protection at a pace the stock has not seen all year.
Short interest, meanwhile, has barely moved. At 11.3% of free float, the short position is essentially unchanged week-on-week, down just 0.3% over the past five sessions after rising roughly 7% over the prior month. The ORTEX short score held at 70.5, ranking in the second percentile of the coverage universe. The lending market gives no sign of pressure on those shorts: availability remains ample at 230%, comfortably above the 52-week low of 173%, and cost to borrow is a modest 0.53%. That combination, a sizable short position with cheap and plentiful borrow, describes a market that is negative on the stock but not remotely squeezed.
The Street had been trimming its view ahead of the print. Wells Fargo cut its target to $53 from $56 on October 19 while holding an Equal-Weight rating. Truist Securities, which maintains a Buy, lowered its target to $62 from $68 on October 12. UBS went further on October 5, dropping its Neutral target to $51 from $61. The consensus target sits at $59, implying roughly 16% upside from the current price of $50.83, but the direction of travel has been consistently lower across multiple houses over the past six weeks. On valuation, the stock trades at a price/earnings multiple of 8.3 and an EV/EBITDA of 6.9, both of which have edged higher over the past 30 days as the share price recovered. The EPS momentum factor scores rank in the 23rd percentile on a 30-day basis, a weak reading, though the dividend score ranks in the 100th percentile, reflecting the yield's relative attractiveness within the sector.
The institutional register shows some purposeful buying in the most recent quarter. LSV Asset Management added 2.56 million shares to reach 4.65 million, the largest single incremental move among the top holders. Dimensional Fund Advisors added 452,000 shares. BlackRock added 268,000. These are value-oriented and quant-driven managers, and their additions, all reported as of September 30, came before the recent weakness in analyst targets. On the activist register, there is no Schedule 13D holder; all five-percent filings are passive 13G disclosures. Notably, The Vanguard Group filed an amendment in March 2026 showing its stake had dropped to zero from 10.12%, with Vanguard Capital Management separately filing a fresh 13G in April at 5.27%.
The stock gained 4.3% over the past week to $50.83, broadly in line with the packaging peer group. AMCR rose 7.1% and SLGN climbed 12.2%, while SW slipped 0.6%. Wikipedia attention for Sonoco spiked to a z-score of 2.4 against its own 90-day history, the highest retail-attention reading in that window, consistent with earnings day traffic rather than a sustained trend.
The next data point to watch is how the put/call ratio settles over the coming sessions, and whether short interest follows the options market's post-earnings pivot or holds at its current elevated level.
Stocks in this article
See the live data behind this article on ORTEX.
Open SON on ORTEX →How this article was generated
- Generated
- 21 Oct 2026, 21:53
- Data as of
- 21 Oct 2026, 21:51
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.